AiPD: Autoinhibited Protein Database

Q9UBP9

Gene name	GULP1 (CED6, GULP)
Protein name	PTB domain-containing engulfment adapter protein 1
Names	Cell death protein 6 homolog, PTB domain adapter protein CED-6, Protein GULP
Species	Homo sapiens (Human)
KEGG Pathway	hsa:51454
EC number
Protein Class

Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

177-279 (Predicted disordered autoinhibitory region) PR

Target domain
Relief mechanism
Assay	cis-regPred

AID

177-279 (Predicted disordered autoinhibitory region)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

References

Yeon JH et al. (2016) "Systems-wide Identification of cis-Regulatory Elements in Proteins", Cell Systems, 2, 89-100

Autoinhibited structure

Activated structure

2 structures for Q9UBP9

Entry ID	Method	Resolution	Chain	Position	Source
6ITU	X-ray	217 A	A	1-168	PDB
AF-Q9UBP9-F1	Predicted				AlphaFoldDB

212 variants for Q9UBP9

Variant ID(s)	Position	Change	Description	Diseaes Association	Provenance
TCGA novel	1	M>?	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
COSM1253922 rs781725363 CA2021295	2	N>S	oesophagus [Cosmic]	No	ClinGen cosmic curated ExAC TOPMed gnomAD
rs753137025 CA2021296	3	R>C		No	ClinGen ExAC TOPMed gnomAD
rs756509880 CA2021297	3	R>H		No	ClinGen ExAC TOPMed gnomAD
rs753137025 CA349983601	3	R>S		No	ClinGen ExAC TOPMed gnomAD
CA2021298 rs778143176	4	A>V		No	ClinGen ExAC gnomAD
TCGA novel	6	S>N	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
CA62089106 rs749465498	8	K>N		No	ClinGen ExAC gnomAD
rs1388779345 CA349983677	12	T>A		No	ClinGen TOPMed gnomAD
rs1383447649 CA349983678	12	T>K		No	ClinGen gnomAD
rs746937734 CA2021323	13	W>*		No	ClinGen ExAC TOPMed gnomAD
COSM3787955 rs1325503305 COSM3787956 CA349983695	14	M>I	pancreas [Cosmic]	No	ClinGen cosmic curated TOPMed gnomAD
CA349983702 rs1367876483	15	H>R	Variant assessed as Somatic; impact. [NCI-TCGA]	No	ClinGen NCI-TCGA TOPMed
CA2021324 rs768506343	16	T>I		No	ClinGen ExAC gnomAD
rs545140276 CA2021325	17	P>T		No	ClinGen 1000Genomes ExAC gnomAD
rs560393029 CA2021326	19	A>T		No	ClinGen 1000Genomes ExAC gnomAD
rs1162613533 CA349983728	19	A>V		No	ClinGen TOPMed
CA2021327 rs769511591	24	F>L		No	ClinGen ExAC TOPMed gnomAD
CA349983761 rs1412103502	24	F>Y		No	ClinGen TOPMed
CA2021329 rs762560085	25	I>T		No	ClinGen ExAC gnomAD
rs896628200 CA62089696	25	I>V		No	ClinGen TOPMed
CA62089697 rs867691291	26	P>L		No	ClinGen gnomAD
CA349983773 rs867691291	26	P>R		No	ClinGen gnomAD
rs765927248 CA2021330	26	P>S		No	ClinGen ExAC gnomAD
rs1446644508 CA349983778	27	Y>C		No	ClinGen gnomAD
rs1244346336 CA349984712	31	F>L		No	ClinGen TOPMed
CA62093920 rs78429023	35	T>K		No	ClinGen Ensembl
CA2021345 rs769411572	40	P>R		No	ClinGen ExAC
rs748010283 CA2021344	40	P>S		No	ClinGen ExAC gnomAD
rs748010283 CA349984843	40	P>T		No	ClinGen ExAC gnomAD
TCGA novel	42	G>*	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
TCGA novel	43	T>A	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
TCGA novel	43	T>missing	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
CA62093922 rs902142227	50	V>I		No	ClinGen Ensembl
rs1433188586 CA538062463	53	L>IC*		No	ClinGen gnomAD
TCGA novel	57	R>K	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
CA62859199 rs368832671	57	R>T		No	ClinGen Ensembl
CA349985254 rs1305803984	58	H>R		No	ClinGen gnomAD
TCGA novel	59	I>M	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
TCGA novel	59	I>Q	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
rs1335367315 CA349985266	60	K>E		No	ClinGen TOPMed
TCGA novel	60	K>N	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
rs1297981618 CA349985284	62	S>C		No	ClinGen TOPMed
rs1233908700 CA349985295	64	G>S	Variant assessed as Somatic; 0.0 impact. [NCI-TCGA]	No	ClinGen NCI-TCGA gnomAD
TCGA novel	66	K>E	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
rs371480920 CA62859200	67	I>V		No	ClinGen Ensembl
rs1308997285 CA349985334	69	K>N		No	ClinGen gnomAD
CA2021369 rs778658447	69	K>Q		No	ClinGen ExAC gnomAD
CA2021370 rs745413094 CA349985337	70	V>L		No	ClinGen ExAC TOPMed gnomAD
CA2021371 rs771414895	72	L>V		No	ClinGen ExAC gnomAD
CA62859207 rs529691749	73	Q>*		No	ClinGen TOPMed gnomAD
rs1164275369 CA349985358	73	Q>R		No	ClinGen TOPMed
rs1468866472 CA349985363	74	I>V		No	ClinGen TOPMed gnomAD
TCGA novel	76	I>M	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
CA2021372 rs777255415	76	I>V		No	ClinGen ExAC gnomAD
TCGA novel	78	G>*	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
rs1250664724 CA349985397	79	V>L		No	ClinGen gnomAD
CA62859212 rs1004068113	82	L>I		No	ClinGen TOPMed
CA62859224 rs1016783522	83	E>K		No	ClinGen TOPMed
rs376744592 CA2021374	84	P>T		No	ClinGen ESP ExAC TOPMed gnomAD
rs1559346330 CA349985432	85	K>Q		No	ClinGen Ensembl
CA62859231 rs962366974	86	T>A		No	ClinGen TOPMed gnomAD
TCGA novel	86	T>I	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
CA349985442 rs1168781199	86	T>K		No	ClinGen gnomAD
CA349983021 rs1416411281	88	E>G		No	ClinGen gnomAD
CA2021399 rs759670044	89	V>F		No	ClinGen ExAC gnomAD
CA349983032 rs1371091574	90	Q>E		No	ClinGen TOPMed
rs1334073023 CA349983047	92	N>D		No	ClinGen gnomAD
rs1285810824 CA349983067	94	Q>R		No	ClinGen gnomAD
CA62866391 rs369711209	96	H>R		No	ClinGen ESP TOPMed
rs1214683641 CA349983084	97	R>G		No	ClinGen gnomAD
CA2021401 rs752693650	98	I>L		No	ClinGen ExAC TOPMed gnomAD
rs760755483 CA2021402	98	I>M		No	ClinGen ExAC gnomAD
CA349983091 rs752693650	98	I>V		No	ClinGen ExAC TOPMed gnomAD
rs764157949 CA2021403	99	S>Y		No	ClinGen ExAC
TCGA novel	101	C>Y	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
CA349983127 rs1429612206	103	D>G		No	ClinGen TOPMed gnomAD
TCGA novel	104	D>N	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
CA349983180 rs1273124741	110	I>T		No	ClinGen TOPMed
rs757130717 CA2021406	113	F>L		No	ClinGen ExAC gnomAD
CA349983205 rs1215627084	114	I>V		No	ClinGen TOPMed
rs778848433 CA2021408	119	E>D		No	ClinGen ExAC gnomAD
CA349983254 rs1410325772	121	N>D		No	ClinGen gnomAD
rs1559359596 CA349983273	123	H>P		No	ClinGen Ensembl
rs545876707 CA2021412	124	L>*		No	ClinGen 1000Genomes ExAC gnomAD
rs754423055 CA2021413	125	C>*		No	ClinGen ExAC gnomAD
rs1310915614 CA349983292	126	Y>H		No	ClinGen gnomAD
rs1354724821 CA349983305	128	F>I		No	ClinGen gnomAD
rs749785708 CA2021416	131	E>K		No	ClinGen ExAC gnomAD
COSM3719463 CA349983343 rs199619350 COSM3719462 CA349983342	132	K>N	haematopoietic_and_lymphoid_tissue [Cosmic]	No	ClinGen cosmic curated TOPMed gnomAD
CA2021417 rs200494157	133	C>S		No	ClinGen ExAC TOPMed gnomAD
rs755577046 CA2021457	134	A>S		No	ClinGen ExAC gnomAD
CA349983843 rs1224118515	137	I>M		No	ClinGen gnomAD
TCGA novel	138	T>A	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
rs868860576 CA62878534	138	T>N		No	ClinGen Ensembl
CA349983847 rs868860576	138	T>S		No	ClinGen Ensembl
CA2021458 rs779291465	140	T>P		No	ClinGen ExAC gnomAD
CA2021459 rs750884700	141	I>V		No	ClinGen ExAC gnomAD
CA349983870 rs1357922096	142	G>D		No	ClinGen gnomAD
CA2021460 rs758746005	143	Q>R		No	ClinGen ExAC gnomAD
rs1264999716 CA349983880	144	A>T		No	ClinGen gnomAD
rs747284653 CA2021463	147	L>V		No	ClinGen ExAC TOPMed gnomAD
rs1282464649 CA349983915	149	Y>C		No	ClinGen gnomAD
rs898655714 CA62878546	149	Y>N		No	ClinGen Ensembl
rs769024034 CA2021464	150	R>G		No	ClinGen ExAC gnomAD
CA349983922 rs1559389395	150	R>K		No	ClinGen Ensembl
TCGA novel	150	R>W	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
rs781524191 CA2021465	151	K>R		No	ClinGen ExAC
CA349983955 rs1337065231	155	S>A		No	ClinGen TOPMed
TCGA novel	157	G>V	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
rs1259520962 CA349983976	158	K>N		No	ClinGen gnomAD
CA2021466 rs377130007	158	K>R		No	ClinGen ESP ExAC gnomAD
rs769857935 CA2021467	159	D>H		No	ClinGen ExAC gnomAD
rs1356983622 CA349984002	162	T>K		No	ClinGen TOPMed
TCGA novel	162	T>S	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
rs369004912 CA349984036	167	A>S		No	ClinGen ESP ExAC TOPMed gnomAD
rs369004912 CA2021470	167	A>T	Variant assessed as Somatic; 0.0 impact. [NCI-TCGA]	No	ClinGen ESP ExAC NCI-TCGA TOPMed gnomAD
rs199688027 CA349984057	170	Q>P		No	ClinGen 1000Genomes ExAC gnomAD
rs199688027 CA2021472	170	Q>R		No	ClinGen 1000Genomes ExAC gnomAD
TCGA novel	172	R>E	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
CA62878559 rs947271518	172	R>I		No	ClinGen TOPMed gnomAD
rs771796407 CA2021494	174	Q>E		No	ClinGen ExAC TOPMed gnomAD
rs1329454926 CA349984103	175	D>G		No	ClinGen gnomAD
CA2021495 rs775180915	176	L>V		No	ClinGen ExAC TOPMed gnomAD
rs763552013 CA2021498	178	T>I		No	ClinGen ExAC gnomAD
rs753411759 CA2021499	181	M>T		No	ClinGen ExAC gnomAD
CA2021500 rs761188427	182	E>K		No	ClinGen ExAC gnomAD
rs1196196734 CA349984159	183	L>F		No	ClinGen TOPMed gnomAD
CA349984158 rs1196196734	183	L>V		No	ClinGen TOPMed gnomAD
CA2021504 rs755455550	188	Q>R		No	ClinGen ExAC TOPMed gnomAD
rs767992135 CA2021505	191	E>G		No	ClinGen ExAC TOPMed gnomAD
CA2021507 rs756340887	192	N>K		No	ClinGen ExAC gnomAD
rs752906524 CA2021506	192	N>T		No	ClinGen ExAC gnomAD
CA2021508 rs777805792	194	L>M		No	ClinGen ExAC gnomAD
TCGA novel	198	Q>E	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
CA2021509 rs143831338 CA2021510	199	V>L		No	ClinGen ESP ExAC TOPMed gnomAD
rs1329358593 CA349984283	201	A>V		No	ClinGen gnomAD
CA349984287 rs778832408	202	P>H		No	ClinGen ExAC gnomAD
rs778832408 CA2021511	202	P>L		No	ClinGen ExAC gnomAD
rs778832408 CA2021512	202	P>R		No	ClinGen ExAC gnomAD
CA2021513 rs771919175	203	P>L		No	ClinGen ExAC TOPMed gnomAD
rs199588499 CA2021555	204	A>T		No	ClinGen ESP ExAC TOPMed gnomAD
rs777660706 CA62881949	206	S>N	Variant assessed as Somatic; 0.0 impact. [NCI-TCGA]	No	ClinGen NCI-TCGA gnomAD
CA349984339 rs1326081912	208	T>I		No	ClinGen gnomAD
CA2021556 rs140726527	209	P>R		No	ClinGen ESP ExAC TOPMed gnomAD
CA2021557 rs769596572	210	K>E		No	ClinGen ExAC TOPMed gnomAD
CA349984351 rs1273505815	210	K>N		No	ClinGen TOPMed gnomAD
rs777523077 CA2021558	211	S>L		No	ClinGen ExAC gnomAD
rs1172109190 CA349984364	213	S>P		No	ClinGen TOPMed
CA349984375 rs1316074402	215	D>N		No	ClinGen gnomAD
CA2021563 rs769102592	216	I>N		No	ClinGen ExAC gnomAD
CA2021562 rs377675952	216	I>V		No	ClinGen ESP ExAC gnomAD
rs749394031 CA62881957	217	F>C		No	ClinGen Ensembl
CA2021565 rs762115675	218	D>N		No	ClinGen ExAC TOPMed gnomAD
CA349984407 rs1245961051	219	M>I		No	ClinGen gnomAD
CA62881960 rs970844612	219	M>V		No	ClinGen TOPMed gnomAD
rs765450501 CA2021566	224	P>A		No	ClinGen ExAC gnomAD
rs750586464 CA2021567	225	I>V		No	ClinGen ExAC gnomAD
CA2021568 rs763080098	226	S>L	Variant assessed as Somatic; 0.0 impact. [NCI-TCGA]	No	ClinGen ExAC NCI-TCGA TOPMed gnomAD
rs766366275 CA2021569	227	H>D		No	ClinGen ExAC TOPMed gnomAD
rs751559772 CA2021570	227	H>Q		No	ClinGen ExAC TOPMed gnomAD
CA2021571 rs537795313	230	S>L		No	ClinGen 1000Genomes ExAC TOPMed gnomAD
CA2021573 rs752574797	231	M>I		No	ClinGen ExAC gnomAD
CA349984486 rs1469663693	232	P>A		No	ClinGen TOPMed gnomAD
CA2021574 rs755902053	233	T>A		No	ClinGen ExAC TOPMed gnomAD
CA2021575 rs777577897	234	R>C	Variant assessed as Somatic; 0.0 impact. [NCI-TCGA]	No	ClinGen ExAC NCI-TCGA TOPMed gnomAD
CA2021576 rs748933734	234	R>H	Variant assessed as Somatic; 0.0 impact. [NCI-TCGA]	No	ClinGen ExAC NCI-TCGA TOPMed gnomAD
rs1339172128 CA349984501	235	N>H		No	ClinGen gnomAD
CA349984520 rs1218089102	237	T>I		No	ClinGen gnomAD
CA2021577 rs770538489	238	Q>R		No	ClinGen ExAC gnomAD
CA349984536 rs1559407077	240	P>S		No	ClinGen Ensembl
CA2021579 rs573288972	243	P>L		No	ClinGen 1000Genomes ExAC TOPMed gnomAD
CA349984555 rs573288972	243	P>R		No	ClinGen 1000Genomes ExAC TOPMed gnomAD
CA2021580 rs769066173	244	S>T		No	ClinGen ExAC gnomAD
CA2021581 rs777082278	247	T>I		No	ClinGen ExAC gnomAD
rs762180852 CA2021582	249	I>S		No	ClinGen ExAC gnomAD
rs374054537 CA2021592	251	R>Q		No	ClinGen 1000Genomes ESP ExAC TOPMed gnomAD
CA2021591 rs752619717	251	R>W		No	ClinGen ExAC gnomAD
CA2021593 rs763974062	254	F>L		No	ClinGen ExAC gnomAD
rs1294313101 CA349984662	258	P>H		No	ClinGen TOPMed
CA349984664 rs1294313101	258	P>L		No	ClinGen TOPMed
CA349984668 rs1559411043	259	F>S		No	ClinGen Ensembl
rs753583830 CA2021594	260	D>G		No	ClinGen ExAC gnomAD
rs367867124 CA2021595	262	F>C	Variant assessed as Somatic; impact. [NCI-TCGA]	No	ClinGen ESP ExAC NCI-TCGA TOPMed
CA2021596 rs778578131	263	N>D		No	ClinGen ExAC gnomAD
CA349984709 rs1211462194	264	C>G		No	ClinGen gnomAD
CA349984711 rs1457660047	264	C>Y		No	ClinGen TOPMed
rs757867674 CA2021598	266	A>E		No	ClinGen ExAC gnomAD
TCGA novel	267	A>T	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
TCGA novel	267	A>V	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
rs1156737527 CA349984756	268	D>N		No	ClinGen TOPMed
CA2021601 rs770185986	270	P>S		No	ClinGen ExAC TOPMed gnomAD
rs1441209488 COSM3938844 CA349984795	271	P>S	oesophagus [Cosmic]	No	ClinGen cosmic curated gnomAD
rs1160801254 CA349984832	274	Q>E		No	ClinGen gnomAD
rs568767997 CA2021602	274	Q>L		No	ClinGen ExAC TOPMed gnomAD
rs868325910 CA62882622	278	D>A		No	ClinGen Ensembl
CA2021603 rs200640424	279	E>D		No	ClinGen 1000Genomes ExAC TOPMed gnomAD
CA2021640 rs779302524	283	G>R		No	ClinGen ExAC gnomAD
TCGA novel	284	F>L	Variant assessed as Somatic; impact. [NCI-TCGA]	No	NCI-TCGA
rs1159546001 CA349985078	285	K>Q		No	ClinGen TOPMed
CA349985131 rs1247898802	291	E>D		No	ClinGen TOPMed
rs375311420 CA62883626	292	G>D		No	ClinGen ESP TOPMed
rs780381570 CA2021643	294	V>A		No	ClinGen ExAC gnomAD
CA2021644 rs549477962	295	F>Y		No	ClinGen 1000Genomes ExAC gnomAD
CA2021646 rs369009419	298	D>N	Variant assessed as Somatic; 0.0 impact. [NCI-TCGA]	No	ClinGen 1000Genomes ExAC NCI-TCGA TOPMed gnomAD
rs761780319 CA2021647	299	P>L		No	ClinGen ExAC gnomAD
CA2021649 rs773083770	303	R>G		No	ClinGen ExAC gnomAD
CA349985205 rs181641969	303	R>K		No	ClinGen 1000Genomes ESP ExAC TOPMed gnomAD
CA2021651 rs181641969	303	R>M		No	ClinGen 1000Genomes ESP ExAC TOPMed gnomAD
rs954112473 CA62883632	303	R>S		No	ClinGen Ensembl
rs181641969 CA2021650	303	R>T		No	ClinGen 1000Genomes ESP ExAC TOPMed gnomAD
rs751158905 CA2021652	304	C>Y		No	ClinGen ExAC TOPMed gnomAD

No associated diseases with Q9UBP9

1 regional properties for Q9UBP9

Type	Name	Position	InterPro Accession
domain	PTB/PI domain	22 - 158	IPR006020

Functions

		Description
EC Number
Subcellular Localization	Cytoplasm	May associate with the cytoplasmic side of the plasma membrane and early endosomes
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category	No pathway information available

1 GO annotations of cellular component

Name	Definition
cytoplasm	The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.

No GO annotations of molecular function

Name	Definition
No GO annotations for molecular function

3 GO annotations of biological process

Name	Definition
apoptotic process	A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
lipid transport	The directed movement of lipids into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Lipids are compounds soluble in an organic solvent but not, or sparingly, in an aqueous solvent.
phagocytosis, engulfment	The internalization of bacteria, immune complexes and other particulate matter or of an apoptotic cell by phagocytosis, including the membrane and cytoskeletal processes required, which involves one of three mechanisms: zippering of pseudopods around a target via repeated receptor-ligand interactions, sinking of the target directly into plasma membrane of the phagocytosing cell, or induced uptake via an enhanced membrane ruffling of the phagocytosing cell similar to macropinocytosis.

2 homologous proteins in AiPD

UniProt AC	Gene Name	Protein Name	Species	Evidence Code
O75052	NOS1AP	Carboxyl-terminal PDZ ligand of neuronal nitric oxide synthase protein	Homo sapiens (Human)	PR
Q8K2A1	Gulp1	PTB domain-containing engulfment adapter protein 1	Mus musculus (Mouse)	PR

10	20	30	40	50	60
MNRAFSRKKD	KTWMHTPEAL	SKHFIPYNAK	FLGSTEVEQP	KGTEVVRDAV	RKLKFARHIK
70	80	90	100	110	120
KSEGQKIPKV	ELQISIYGVK	ILEPKTKEVQ	HNCQLHRISF	CADDKTDKRI	FTFICKDSES
130	140	150	160	170	180
NKHLCYVFDS	EKCAEEITLT	IGQAFDLAYR	KFLESGGKDV	ETRKQIAGLQ	KRIQDLETEN
190	200	210	220	230	240
MELKNKVQDL	ENQLRITQVS	APPAGSMTPK	SPSTDIFDMI	PFSPISHQSS	MPTRNGTQPP
250	260	270	280	290	300
PVPSRSTEIK	RDLFGAEPFD	PFNCGAADFP	PDIQSKLDEM	QEGFKMGLTL	EGTVFCLDPL

DSRC